{"SPECIMEN TYPE": "SPECIMEN TYPE Blood", "SPECIMEN SITE": "SPECIMEN", "DATE OF COLLECTION": "DATE OF COLLECTION 11 March 2021", "REPORT DATE": "29 Mar 2021", "Biomarker Findings": ["Blood Tumor Mutational Burden - 18 Muts/Mb", "Microsatellite status - MSI-High Not Detected", "Tumor Fraction - 19%", ""], "Genomic Findings": ["For a complete list of the genes assayed, please refer to the Appendix.", "FBXW7 Q41*", "STK11 L85*", "BRAF K601N", "KRAS G12R", "APC rearrangement exon 16", "ATRX S1125fs*28, inversion exons", "3-9, L767fs*1", "CDKN2A/B p16INK4a Y44fs*1", ""], "Blood Tumor Mutational Burden - 18": [["Atezolizumab", "Cemiplimab", "Durvalumab", "Nivolumab", "Pembrolizumab"], ["Avelumab"]], "APC - rearrangement exon 16": [["p. 10", "1015-1G>T, R635Q", "p. 10"], ["p. 12", "p. 12"]], "CDKN2A/B - p16INK4a Y44fs*1": [["p. 11", "p. 11"], ["p. 13", "p. 13", "p. 14"]]}